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ABSTRACT The amyloid A(10–35)-NH2 peptide is simulated in an aqueous environment on the nanosecond time scale.
One focus of the study is on the validation of the computational model through a direct comparison of simulated statistical
averages with experimental observations of the peptide’s structure and dynamics. These measures include (1) nuclear
magnetic resonance spectroscopy-derived amide bond order parameters and temperature-dependent H proton chemical
shifts, (2) the peptide’s radius of gyration and end-to-end distance, (3) the rates of peptide self-diffusion in water, and (4) the
peptide’s hydrodynamic radius as measured by quasielastic light scattering experiments. A second focus of the study is the
identification of key intrapeptide interactions that stabilize the central structural motif of the peptide. Particular attention is
paid to the structure and fluctuation of the central LVFFA hydrophobic cluster (17–21) region and the VGSN turn (24–27)
region. There is a strong correlation between preservation of the structure of these elements and interactions between the
cluster and turn regions in imposing structure on the peptide monomer. The specific role of these interactions in relation to
proposed mechanisms of amyloidosis is discussed.
BACKGROUND
A persuasive argument has been made to support the hy-
pothesis that amyloid peptide deposition is “a necessary but
not sufficient factor for the pathogenesis” of Alzheimer’s
disease (Selkoe, 1991). From the analysis of experimental
studies of amyloidogenesis, several distinct scenarios for
fibril formation and elongation have evolved (Lansbury,
1996; Maggio and Mantyh, 1996; Teplow, 1998; Rochet
and Lansbury, 2000). In one scenario, largely unstructured
peptide monomers in solution cluster and form nuclei
(Lansbury, 1996). When the cluster reaches a critical “nu-
cleus,” that nucleus then grows to form full length fibrils by
the addition of monomers to the existing fibril ends (Lo-
makin et al., 1996, 1997). In a second scenario, there is first
the formation of peptide “protofibrils” of intermediate
length (Harper, 1997a; Walsh, 1997). Such protofibrils then
associate to form full length fibrils (Walsh, 1997; Harper,
1997b). Once the full length fibrils are formed, additional
amyloid peptide may add directly to existing fibrils (Esler,
1996a; Kusumoto, 1998). Finally, monomers may associate
to form micelles. Those micelles may convert to fibril nuclei
upon reaching a critical size (Lansbury, 1996; Lomakin et
al., 1996, 1997). The relative importance of each of these
possible pathways has not yet been established.
Once the fibrils are formed, it has been clearly demon-
strated that the process of elongation of those existing fibrils
occurs through the process of monomeric peptide binding to
fiber ends (Esler, 1996a) and that the kinetics are first order
in the concentration of monomeric peptide. This key obser-
vation has motivated studies of the simple first order kinet-
ics of fibril elongation (Teplow, 1997; Kusumoto, 1998).
In such a mechanistic theory of fibril elongation an im-
portant question is raised. How does the peptide’s solution
phase structure influence the rate of fibril elongation? The
wild-type (WT) peptide congener has been shown to exist in
a loosely formed collapsed coil state in aqueous solution
(Lee et al., 1995; Zhang et al., 1998). The structure of the
collapsed coil is characterized by a central hydrophobic
cluster (CHC) in the LVFFA (17–21) region. There is also
a dominant turn in the VGSN (24–27) region that is ob-
served in both the aqueous solution structure and the tri-
fluoroethanol (TFE)-water solution structure, which shows
two short -helical regions (Barrow et al., 1992). This has
been supported by H chemical shift measurements taken as
a function of temperature (Zhang, 1999), which have shown
very small changes in the chemical shift over a range of
temperature from 5 to 35°C in the VGSN region. Analysis
of the exposed hydrophobic surface area of the collapsed
coil structure shows that the peptide presents a large hydro-
phobic patch that could play an important role in the initial
deposition of the peptide monomer on the fibril surface.
Experimental analysis of the E22Q Dutch mutant of the
amyloid peptide has shown it to be significantly more active
than the WT peptide with a twofold increase in the rate of
fibril elongation and deposition competence. Experimental
measurement of the H proton chemical shift in the wild
type and Dutch mutant indicates that the structures of the
monomeric peptides in solution are similar (Esler et al.,
2000). The increased deposition rate observed for the Dutch
mutant has been explained in terms of a more disordered
solution state relative to the WT peptide (Esler et al., 2000).
The looser structure is believed to lower the entropic barrier
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for opening of the peptide, which is necessary in the depo-
sition process.
Experimental studies of A(10–35)-NH2-cycloH14K-
E22, an engineered cyclic peptide congener, has demon-
strated that the covalently locked structure is similar to the
structure of the WT peptide (Esler et al., 2000). However,
the structurally locked cyclic congener is found to be inac-
tive in deposition. This has been interpreted as a demon-
stration that the peptide must be allowed to adopt an ex-
tended conformation in order to add to an amyloid template.
Nuclear magnetic resonance spectroscopy (NMR) struc-
tural analysis of the F19T congener of the amyloid peptide
congener in aqueous solution indicates that there is a serious
disruption of peptide structure in the CHC region of the
mutant peptide (Esler et al., 1996b). This disruption of the
CHC is correlated with a diminished ability of the peptide to
add to well-formed amyloid deposits. Therefore, in both the
F19T congener and the E22Q Dutch mutant, the amyloid
peptide monomer in solution is found to be less constrained
in the coil state. In the case of the E22Q Dutch mutant and
the WT peptide, the structure of the CHC is preserved and
peptide activity is normal or increased. In the case of the
cyclic congener, the CHC is preserved and the peptide
initially adheres to the fibril. However, the restricted peptide
cannot undergo the necessary conformational transition re-
quired to add to the fibril. In the case of the F19T congener,
the CHC and hydrophobic patch are disrupted and activity is
diminished (Esler et al., 1996b).
The scenario that emerges from these studies is one in
which a partially structured collapsed coil state encounters
the fibril end through diffusion and adheres to the fibril end
to bury its hydrophobic patch. The peptide deposits itself on
the fibril end, resulting in a loosely formed complex. The
peptide/fibril complex then undergoes reorganization to ac-
commodate the peptide in a more fully deposited (product)
state. The reorganization step may involve conformational
changes in the peptide and/or the fibril end. The activation
energy for the fibril elongation is associated with peptide/
fibril reorganization.
All of this evidence clearly points to a central role of the
structure and dynamics of the peptide monomer in the
mechanism of fibril elongation. There is evidence that the
structure of the monomer in solution is intimately related to
the process of monomer deposition and reorganization on
the preexisting fibril surface. Therefore, knowledge of the
structure of the monomer is essential in understanding the
rate of diffusion of the monomer in solution.
In this study, we develop a model of the WT peptide
congener in aqueous solution and use that model to simulate
the peptide dynamics on a nanosecond time scale. Our focus
is on validating our model by direct comparison with ex-
perimental studies and augmenting the existing body of
experimentally derived information regarding the peptide’s
structure and dynamics. Specifically, we pose the following
questions. (1) How well can simulation represent the com-
puted NMR structural order parameters for the peptide in
solution, the rate of peptide diffusion, and the observed
hydrodynamic radius? (2) Are there structural motifs that
characterize the conformations of the monomer in solution?
(3) What interactions stabilize the monomer structure and
what role do those interactions play in the peptide’s “activity”?
To answer these questions, multiple trajectories were run
originating from independent starting conformations of the
peptide. From these trajectories, the peptide structure, in-
tramolecular fluctuations, and overall peptide dynamics
were analyzed. Direct comparison is made with a variety of
experimental observables. The analysis points to specific,
key interactions that stabilize the structure of the peptide
monomer. The role of these interactions in the process of
peptide deposition and fibril elongation is discussed.
METHODS
The WT peptide congener is depicted in Fig. 1. The structure was derived
using NMR by Lee and coworkers (Zhang et al., 2000) from distance
geometry calculations employing NMR-derived NOE restraints. The col-
ored regions are Tyr10-Glu11-Val12 (purple), His13-His14 (gray), Gln15-
Lys16 (purple), Leu17-Val18-Phe19-Phe20-Ala21 (red), Glu22 (green),
Asp23 (pink), Val24-Gly25-Ser26-Asn27 (yellow), Lys28-Gly29-Ala30-
Ile31-Ile32-Gly33-Leu34-Met35 (purple). Of primary interest in this work
is the 17–21 LVFFA segment (red) that forms the central hydrophobic
cluster and the 24–27 VGSN (yellow) segment that forms a stable turn.
Our simulations each originated from one of a set of four initial peptide
structures that were chosen from two families of C-terminus conformers.
Those structures resulted from a distance geometry refinement combined
with a molecular dynamics annealing/minimization procedure employing
experimentally derived NOE restraints. NMR heteronuclear relaxation data
was also used to successfully compute S2 order parameters for a number of
the backbone amide H-N vectors. Further fitting of the relaxation data
together with estimation of the shape factors and hydrodynamic radii from
NMR based translational diffusion measurements allowed for two inde-
FIGURE 1 This master figure identifies the important groups of residues
that compose the wild-type congener amyloid (10–35)-NH2 peptide.
From the N-terminus the groups are Tyr10-Glu11-Val12 (blue), His13-
His14 (gray), Gln15-Lys16 (blue), Leu17-Val18-Phe19-Phe20-Ala21
(red), Glu22 (green), Asp23 (purple), Val24-Gly25-Ser26-Asn27(yellow),
Lys28-Gly29-Ala30-Ile31-Ile32-Gly33-Leu34-Met35 (blue).
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pendent estimates of the rotational correlation time which were in good
agreement. For completeness, in this section we provide a brief description
of the experimental approach used to determine the set of initial structures,
order parameters and peptide diffusion constants employed in our study.
Further details may be found elsewhere (Lee et al., 1995; Zhang, 1999;
Zhang et al., 2000).
In the remainder of this section we describe the simulation model
employed in our study. The standard methods used to determine the
peptide’s structure, NMR order parameters, time dependent structural
changes, and rates of self-diffusion are briefly summarized.
Experimental methods
NMR sample preparation
A Merrifield solid phase synthesis was used to build the A(10–35)-NH2
peptide that was subsequently purified to greater than 98% homogeneity by
HPLC. A first sample was uniformly labeled with 2H at Val12, Leu17,
Val18, Phe19, Ile32, and Leu34, 15N in the backbone position of Phe19,
Val24, Gly25, and Gly29, and 13C uniformly at Val24, in the -methyl
groups of Ala21 and Ala30 and the -methyl group of Met35. A second
sample was uniformly labeled with 2H at Val12, Leu17, Phe19, Val24,
Ile31, and Leu34, 15N in the backbone position of Val18, Phe20, Gly25,
and Gly29, and Gly33, and 13C uniformly at Val24, in the -methyl groups
of Ala21 and Ala30 and the -methyl group of Met35. The use of 15N- and
13C-labeled samples resulted in the unambiguous identification of a larger
number of 1H-1H NOEs, thereby increasing the number of restraints that
could be subsequently employed in the structural refinement. The use of
extensive 2H labeling of Leu, Val and Ile residues aided in the identifica-
tion of cross peaks in the Leu, Val, Ile CH3 fingerprint region. This effort
was only partially successful in resolving the methyl resonances of Ile31,
Ile32, and Leu34. The 2H labeling of the Phe19 and Phe20 residues aided
in the unique assignment of these key residues of the central hydrophobic
core in the crowded aromatic region.
Dried samples were used to make an approximately 250 M concen-
tration of peptide in either 100% D2O or a 90:10 ratio of H2O:D2O with 0.5
mM sodium 3-(trimethylsilyl)propionate-2,2,3,3,-d4 (TSP) where the pH
was adjusted to approximately 5.6 using hydrochloric acid or ammonium
hydroxide (deuterated when appropriate). The resulting solutions were
immediately centrifuged for 10 min at 100,000  g and then, the centrif-
ugation was continued to achieve a sedimentation of particles greater than
0.5 s. That criterion would demand, depending on the centrifuge, ultra-
centrifugation for 100 to 200 hours. The intensive centrifugation is an
essential step in the preparation of the samples of predominately mono-
meric peptide required for structural analysis. Intensive centrifugation has
been shown to lead to samples 200–300 M in peptide that are stable and
show no signs of aggregation for periods in excess of 3 years.
NMR experiments
Data for 1H spectra were collected for samples maintained at 10°C on 11.7
T (located at Boston University) and 17.6 T (located at Oxford Instruments,
Oxford, UK) Varian UNITYplus NMR machines employing pulse field
gradient probes. The design of the structural work, presented in detail
elsewhere (Lee et al., 1995; Zhang et al., 2000), is the following. The
chemical shifts, referenced to internal TSP at 0.00 ppm, were detected
using two-dimensional waveform gradient suppression total correlation
spectroscopy (TOCSY) with frequency discrimination achieved through
the time-proportional phase-incrementation (TPPI-States) method. 1H de-
tected heteronuclear multiple quantum coherence nuclear Overhauser en-
hancement spectroscopy (NOESY) spectra were taken to determine the
isotope filtered 15N edited spectra.
Structural refinements using NOE restraints
Structures of the peptide that were consistent with the experimentally
derived NOE restraints were computed using the Distance Geometry II
module of the Insight II computational software package (Molecular Sim-
ulations, San Diego, CA). There were 55 inter-residue and 24 intra-residue
NOEs observed for the peptide’s N-terminal (Tyr10-Lys16) region; 86
inter-residue and 31 intra-residue NOEs were detected for the central
hydrophobic cluster (Leu17-Ala21); 46 inter-residue and 22 intra-residue
NOEs were measured for the extended core (Glu22-Lys28); for the C-
terminal peptide region (Gly29-Met35) 28 inter-residue and 24 intra-
residue NOEs were observed. The measured NOEs resulted in the total of
84 sequential, 66 medium range (i,i  2 or i,i  3), and 32 long-range
restraints used in the distance geometry calculations.
A set of 40 peptide structures resulted from the distance geometry
calculations. A subset of those structures was then used as input in a series
of molecular dynamics (MD) calculations performed using the DIS-
COVER program of the Insight II computational software program. The
MD calculations employed loose harmonic restraints of atoms about their
initial positions and consisted of 1 ps of dynamics at 1000 K followed by
a stepwise cooling to 200 K at a rate of 100 K/ps. The energy of the final
“annealed” structure was then minimized using the conjugate gradient
algorithm. Of the starting set of 40 peptide structures, following the MD
annealing and minimization procedure, 15 structures with the lowest po-
tential energy (in the absence of solvent) were selected to represent the
solution state ensemble of monomeric peptide. The 15 final structures can
be grouped in two main structural families depending upon the orientation
of the C-terminus. The root mean square deviation (RMSD) of the back-
bone atoms (N-C-C) has been calculated for both families separately. It
showed consistently smaller values for one of the two families in every
region of the peptide. The RMSD in the region of the central hydrophobic
cluster and extended core (Lys 16-Lys28) was 0.47 Å and 0.58 Å respec-
tively for the two families of structures. This result is different from the one
reported by Lee (Zhang et al., 2000), since a different definition of the
RMSD has been used (Molecular Simulations). Outside of the peptide’s
core region, the C-terminal residues (Gly29-Met35) were relatively well-
structured in one of the two families with a backbone RMSD of 0.57 Å, and
less well structured in the other with an RMSD of 1.00 Å. However, the
N-terminal region was significantly less structured in solution resulting in
an absence of medium- and long-range NOE restraints with RMSD values
of 1.01 and 1.20 Å. The four initial structures employed in our MD
simulations were taken to be the two lowest-energy structures from each
family.
Diffusion
Diffusion constants for the peptide were measured as described elsewhere
(Tseng et al., 1999). Briefly, the pulse field gradient probe was used to
tailor a trapezoidal spatial gradient, the amplitude of which could then be
arrayed. The NMR gradient amplitude dependence of the signal intensity
was then measured and fitted to an exponential function of the squared
gradient amplitude. The decay rate of the exponential was assumed to be
proportional to the peptide diffusion constant. Ten values of the gradient
amplitude were used in each of three complete measurements.
Measurement of 15N relaxation times
One approach to the determination of the amide bond vector order param-
eters, S2 is known as spectral density mapping (Peng and Wagner, 1992,
1995). In that approach, a series of rates for (1) longitudinal 15N magne-
tization relaxation, RN(Nz); (2) in-phase 15N single quantum coherence
relaxation, RN(Nx); (3) antiphase 15N single quantum coherence relaxation,
RHN(2HzN Nx); (4) longitudinal heteronuclear two-spin order relaxation,
RH(2HzN Nz); (5) amide proton longitudinal relaxation, RH(HzN); and (6)
longitudinal cross-relaxation between the amide proton and nitrogen,
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RN(HzN7 Nz), were measured. A set of constraint equations relaters the set
of relaxation rates to the spectral density J() at five frequencies 0, H, N,
and H  N, and the sum of the proton longitudinal relaxation rate
constants. The spectral density may then be fit using a model free approach
to derive the S2 order parameters (Cavanagh et al., 1996).
In this work, the reduced spectral density mapping protocol was fol-
lowed (Peng and Wagner, 1995). It is assumed that at high magnetic fields
J(H)  J(N  H)  J(H  N), i.e., the differences are less than the
typical error in measuring relaxation rates. This assumption eliminates two
of the six (relaxation) equations, reducing the set of equations to four.
However, the sum of the proton longitudinal relaxation rate constants is,
under this assumption, decoupled, thereby resulting in three equations
relating three values of the spectral density J(0), J(N), and J(H) to
RN(Nz), RN(Nx), and RN(HzN 7 Nz) or equivalently T1, T2, and the NOE
where the steady-state heteronuclear NOE, , is defined (Peng and Wag-
ner, 1992):
 
	H
	N
RNHzN7 Nz
RNNz
. (1)
The relaxation rates measured at B0 field strength of 11.74 T were then
used to solve for the spectral density at the three specified frequencies. The
spectral density was, in turn, fitted using the Lipari-Szabo model free
formalism, which incorporates overall molecular reorientation with a time
constant 
c (the mean time required for the molecule to rotate by one
radian) and intramolecular or “internal” motions with a time constant 
int
(Lipari and Szabo, 1982a,b). By fitting the spectral density to the pre-
scribed functional form, it was possible to derive the squared generalized
order parameters, S2, for the individual amide bond vectors. In that pro-
cedure, J(0) was ignored and J(N) and J(H) were fit to determine values
of S2 and 
int using a value of 
c 	 1.3 ns/rad. Those parameters were then
used to predict J(0). The experimentally derived values of J(0) were
somewhat higher than the back-predicted values, suggesting the presence
of conformational exchange. The back-predicted values are nonetheless in
reasonable agreement with the experimental values. This suggests that the
resulting values of S2 are reliable.
Simulation model of the WT peptide congener in
aqueous solution
The NMR structure of the amyloid -peptide served as the starting con-
figuration of the simulation. The peptide was centered in a rhombic
dodecahedron cell that was carved from a cubic box of 50 Å on a side and
filled with 2113 water molecules (for a 31 mM concentration of peptide).
Periodic boundary conditions were applied to avoid edge effects. The
energetics of the A peptide in water was simulated using the version 22
potential energy function of the CHARMM program (Mackerell et al.,
1998). The potential energy cutoff distance for the nonbonding interactions
was 12.0 Å. Ewald summation was used to evaluate the electrostatic
interactions. The use of the SHAKE constraint algorithm throughout the
simulation, to keep the lengths of the bonds involving hydrogen atoms
fixed at their equilibrium values, allowed for the use of a time step of
integration of 2 fs using the CHARMM program (Brooks et al., 1983).
After the equilibration period of 200 ps, a production run of 1 ns was
completed with an average temperature of 300K. Coordinates and energetic
data were collected every 200 fs.
The starting configurations for our peptide simulations were taken from
a set of coordinates derived from distance geometry calculations and
modeling with NMR derived NOE restraints. The four structures are
depicted as ribbons in Fig. 2. The four 1-ns trajectories are denoted T1, T2,
T3, and T4. What is in common to the four structures is the conformation
of the 17–27 region containing the LVFFA and VGSN substructures.
Outside of that core structure there is considerable disorder. In those
regions, the experimentally derived restraints are fewer, but nonetheless
consistent with some residual structure.
Measures of peptide
dynamics and reorganization
We employ a number of useful measures of the peptide dynamics, includ-
ing the rate of translational diffusion of the peptide and variations in the
compactness of the peptide as measured by the radius of gyration and
peptide end-to-end distance. Comparisons are made with the theoretical
estimates for a freely jointed linear chain.
Self-diffusion constant for the peptide
The mean-square displacement of the center-of-mass of the peptide was
computed as a function of time for the trajectories T1, T2, T3, and T4. The
diffusion constant of the peptide monomer was estimated using the Ein-
stein relation

rCOMt2 6Dt (2)
which is expected to hold in the limit of long times. The mean square
displacement was computed over the length of the trajectory and the slope
was measured to determine the diffusion constant.
The magnitude of the diffusion constant was also estimated using the
Kubo relation,
D
1
3 
0


vCOMtvCOM0dt (3)
where 
vCOM(t)vCOM(0) is the velocity autocorrelation function for the
center-of-mass of the peptide. The velocity autocorrelation function was
computed and fitted to an exponential function to estimate the time integral
and D.
Peptide end-to-end distance
The end-to-end distance of the peptide was defined by the distance sepa-
rating the first N atom of the N-terminus of Tyr10 and the second end N
atom attached to the carbonyl oxygen of the C-terminal residue Met35.
This is equivalent to a sum along the backbone according to
re 
i
li (4)
FIGURE 2 The four initial configurations of the peptide superimposed
to best overlap the 17–21 LVFFA regions of the peptides. Each initial
structure was generated through a refinement procedure using NOE re-
straints derived from NMR experiments on the wild-type congener amyloid
(10–35)-NH2 peptide by Lee and coworkers. Note the significant disorder
outside of the central core region.
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where li is the vector connecting the consecutive N atoms along the
back-bone between the N- and C-termini. This distance was computed for
each simulation. We write the ensemble-averaged value 
re2, which is
computed by averaging over the MD trajectories. Large changes indicate
significant reorganization in the global structure of the peptide.
Radius of gyration
The radius of gyration for the peptide was computed using all of the
peptide atoms in the standard formula (Berne and Pecora, 1976)
rg2 
k
N
mkrk rCOM2
k
N
mk (5)
where rCOM is the peptide’s center of mass, rk is the position of the kth
atom in the peptide, and mk is its mass. When the masses are all equal, this
expression is equivalent to a sum over all atom pair distances rij as
rg2
1
N2 
ij
rij2 (6)
In our computations, rg was computed using (1) all atoms and (2) only the
heavy (non-hydrogen) atoms. Each computation was carried out over many
configurations of the peptide generated over the trajectory to determine the
ensemble-averaged value 
rg2.
Characterizing the peptide structure in solution
Direct visualization of the peptide structure’s time evolution was used as
part of the analysis of the peptide dynamics. In addition, we analyzed the
intramolecular hydrogen bond network by computing a measure of persis-
tence for all possible hydrogen bonds. We also analyzed the evolution of
the peptide structure by computing the solvent exposed surface area of the
total peptide and the hydrophobic patch centered about the LVFFA region.
These methods are defined below.
Recognizing intramolecular hydrogen bonds
In each stored configuration, the peptide was analyzed for hydrogen
bonding groups for all possible donors and acceptors. The hydrogen
bonding frequency was then computed for the full simulation by dividing
the number of snapshots showing hydrogen bonds by the total number of
snapshots. The approximate definition of the hydrogen bond that was used
is that the donor and acceptor atoms must be at a distance shorter than or
equal to 2.5 Å and the angle between the donor and acceptor diatomic
groups is in the range 113–180° (Simmerling et al., 1995).
Solvent exposed surface area of the LVFFA region
The atomic exposed surface area was computed by the method described
by Wesson and Eisenberg (1992) and originally developed by Lee and
Richards (1971). Essentially, the solvent exposed surface area of each atom
was defined as the area exposed to contact by a water probe of diameter 2.8
Å. The total surface area for the peptide in a modeled extended configu-
ration was computed to represent an upper bound on the surface area of the
peptide. Each trajectory was then analyzed by computing the total solvent
exposed surface area of the whole peptide molecule and the atoms com-
posing the LVFFA region.
Characterizing internal motions: Lipari-Szabo
NMR order parameters
We follow the standard “model free” analysis of Lipari and Szabo
(1982a,b). The motion of the peptide can be described by a correlation
function C(t) for the orientation of a peptide backbone amide bond vector.
Assuming that the internal motions are uncorrelated with the overall
molecular tumbling, C(t) can be separated into two contributions: one for
the internal motions, Cint(t), and the other for the overall molecular rota-
tion, Ctumb(t).
Ct CtumbtCintt
1
5 e
t/
0Cintt . (7)
Cint(t) is given by
Cintt
4
5 
r
61 
m	2
2 Y2mt,tY*2m0,0rt3r03 	
(8)
where Y2m(, ) are the second order spherical harmonics and  and  are
the spherical polar angles that specify the orientation of the internuclear
NH amide bond vector in the molecule-fixed coordinate frame.
The internal motions of the peptide can be characterized by the two
parameters S2, a generalized order parameter, and 
int, an effective corre-
lation time, defined through
S2 lim
t3
Cintt
4
5 
r
61 
m	2
2  Y2m,r3 	 
2
(9)
and

int
1
Cint0 S2 
0
T
Cintt S2dt (10)
where T is the time after which Cint(t) 	 S2. Cint(0) is the value of the
internal correlation function at time zero.
S2 is a measure of the degree of freedom of the motion of the intermo-
lecular amide bond vector; S2 is equal to 1 if the motion is completely
restricted and is equal to 0 for isotropic motion. In order to separate the
overall molecular rotation from the internal motion, every coordinate frame
of the 1 ns trajectory was translated and rotated until the root mean square
displacement with respect to a reference configuration (t 	 0) was mini-
mized (Philippopoulos and Lim, 1994).
RESULTS
This section summarizes the analysis of the four nanosec-
ond trajectories of the solvated A-peptide congener dy-
namics. The peptide dynamics is described and connection
with experiment is made through the computation of NMR
order parameters and rates of peptide self-diffusion and
reorganization.
Peptide structure in solution
The structural dynamics of the peptide is depicted for the
four trajectories in Fig. 3. In each “movie” the peptide is
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rendered every 100 ps during the nanosecond duration of
the run. In trajectories T1, T2, and T4 the core of the peptide
structure is seen to be maintained. The N- and C-terminal
peptide regions are less well structured.
The character of the global peptide fluctuation is even
more apparent in Fig. 4, in which the snapshots of the
peptide depicted in Fig. 3 are reoriented so as to best fit the
LVFFA (17–21) region for all structures. A striking feature
is the strong structural integrity of the central core of the
peptide, in particular the LVFFA (17–21) region and the
VGSN (24–27) turn region. This is the case in all trajecto-
ries. A slight difference in simulation T3 is that the core of
the structure is disrupted and the end-to-end distance in the
peptide is significantly decreased over the simulation run.
This transition will be discussed in detail below.
Hydrogen bond formation
A plot of the hydrogen bond frequency, computed as the
fraction of time a hydrogen bond is well-formed during the
trajectory, is shown in Fig. 5. In simulation T1, the hydro-
gen bonds that are most persistent include Glu11(O)-
His13(HN), seen in all four runs, Val18(O)-Lys28(HN),
Ser26(hydroxylic H)-Asn27(HN), and Lys16(O)-Val18(HN).
Other hydrogen bonds that are formed in this trajectory
include Leu17(O)-Phe19(HN), Ala21(O)-Asp23(HN), and
Lys28(O)-Val18(HN). We find that for this run, amino
acids in the VGSN turn region do not form hydrogen bonds
with the LVFFA region. During this run, the only hydrogen
bonds to form in either region are those internal to the
region.
In simulation T2 we find Asn27 (side chain acyl oxygen)-
Ala30(HN), Glu11(O)-His13(HN), and Ile32(O)-Asn27
(sidechain HN) to be persistent hydrogen bonds. In addition
to those hydrogen bonds, also seen in the T2 run are
hydrogen bonds between Phe20(O)-Ser26(hydroxylic H),
Ala21(O)-Gly25(HN), Leu17(O)-Phe19(HN), and Ala21(O)-
Asp23(HN), all of which involve at least one atom of the
LVFFA region. Two of these bonds are between the LVFFA
and the VGSN regions. The last two bonds listed above are
also present in the T1 run. In simulations T2 and T4, there
is a hydrogen bond between Asp23(O)-Gln15(HN).
In simulation T3, the peptide structure appears to be more
open. Persistent hydrogen bonds are formed between
Ser26(hydroxylic O)-Asn27(HN), His14(O)-Val18(HN),
and His13(O)-Gln15(HN). The backbone oxygen of the
Phe19 residue interacts with both Gly25(HN) and
Val24(HN). Those interactions involve residues from the
LVFFA and VGSN regions. A hydrogen bond between
Ala30(O)-Ile32(HN) is also seen. Hydrogen bonds involv-
FIGURE 3 A “movie” composed of snapshot configurations taken every
100ps along the nanosecond trajectories T1, T2, T3, and T4, respectively.
FIGURE 4 A “collage” composed of snapshot configurations taken ev-
ery 100ps along the nanosecond trajectories T1, T2, T3, and T4, respec-
tively. The peptide backbone structures are overlapped to best fit the 17–21
LVFFA regions of the peptide.
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ing Ala21 and Leu17 occur infrequently. This run presents
the smallest number of common hydrogen bonds of all the
trajectories.
In the T4 simulation, there is a high degree of structure.
The H-bonds involve many residues; with the exception of
Phe20, all of the amino acids between His13 and Asp27 are
involved in hydrogen bonds within the region. The residues
of the LVFFA region form many hydrogen bonds in the T4
run and many of those hydrogen bonds are formed with
atoms in the VGSN region. Examples of such hydrogen
bonds include Asp23 (side chain O)-Val18(HN), Asp23
(side chain O)-Leu17(HN), Phe19(O)-Asn27(HN),
Val18(O)-Ala21(HN), Val18(O)-Val24(HN), Ala21(O)-
Ser26(HN), and Ala21(O)-Gly25(HN). The backbone oxy-
gen atom of the Asp23 residue also interacts with the
backbone amide hydrogens of Gln15 and Lys16. Hydrogen
bonds between Val24(O)-Gln25(HN), His13(O)-Lys16
(sidechain HN) and Glu22(O)-His14 (sidechain HN) are
also seen. These extensive hydrogen bond networks are
important to the stabilization of the core peptide structure.
Solvent-exposed surface area
The exposed hydrophobic surface area is thought to be
crucial to the peptide’s ability to recognize and adhere to the
fibril end. The solvent-exposed surface area of the peptide is
depicted in Fig. 6 for both the total peptide and the LVFFA
central hydrophobic cluster region. Averaging over fluctu-
ations, the LVFFA hydrophobic patch is approximately 400
Å2 in extent, compared with the surface area of approxi-
mately 2600 Å2 of the peptide as a whole.
There is a relatively high contribution of hydrophobic
residues to the solvent-exposed surface area of the peptide
in solution. It is interesting to notice that the nonpolar
surface area is not evenly distributed on the peptide mole-
cule, but is localized in a continuous patch on about one-
third of the surface (Zhang et al., 2000).
In the T3 and T4 simulations, as the total solvent-exposed
surface area of the peptide increases, the radius of gyration
also increases. Note also that the T4 simulation shows the
smallest values for the solvent-exposed surface area. That
simulated structure is also the most rigid with small root-
mean-square (RMS) atomic fluctuations and S2 values.
Measures of peptide
dynamics and reorganization
The most commonly used measure of the fluctuation in a
peptide structure during a dynamic simulation is the RMS
deviation in the position of each atom from its average value
computed over the full simulation run. Those RMS devia-
tions are plotted in Fig. 7 for the four runs. The magnitude
of the RMS fluctuations provides the general description of
the large scale motion of the N- and C-terminal regions.
Large fluctuations also occur in the loop region centered
about residue Glu22. The overall fluctuations in T4 are
significantly lower than in the other three runs. In fact, the
fluctuations in T4 are on the order of 1 Å, similar in
magnitude to fluctuations observed in simulations of larger,
globular proteins. Fluctuations in runs T1, T2, and T3 are
significantly larger, on the order of 2 Å. In the T3 simula-
FIGURE 5 Plot of the hydrogen bonding
probabilities for simulations T1, T2, T3, and
T4, respectively. Hydrogen bond acceptors
are noted along the x-axis and donors are
indicated along the y-axis. The acceptors
indicated with single letters are side chain
groups; those that follow are backbone car-
bonyl oxygen atoms. Similarly, the donors
indicated with single letters are side chain
groups; the remaining donors are backbone
amide hydrogen atoms. On all four plots,
different styles of boxes have been used to
identify atoms from different regions on the
peptide: rectangular solid line boxes for the
LVFFA and oval solid line boxes for the
VGSN region. Hydrogen bonds common to
at least two different trajectories are indi-
cated with an additional box, whose shape
and line type are common among the
trajectories.
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tion there are very small values of S2 for Ala21 and for
residues 26–35. This is in agreement with the large RMS
values for those regions.
Various NMR studies such as the proton chemical shifts
show these regions to be particularly well structured in
aqueous solution and reasonably insensitive to changes in
temperature in the 5–35°C range (Zhang, 1999; see Fig. 8).
In general, it can be seen that regions of small differential
chemical shift correspond to regions of small RMS fluctu-
ations. The overall picture is one of the peptide as a col-
lapsed coil with significant structure imposed by the stable
structure of the CHC LVFFA (17–21) and VGSN (24–27)
turn regions and stabilized by their interactions (Zhang et
al., 1998).
Peptide self-diffusion
The translational self-diffusion constant for the amyloid
peptide was computed using the Einstein relation for the
mean-square displacement of the peptide’s center of mass.
The results are depicted in Fig. 9, which shows the fits to the
initial linear regions of the mean-square displacement and
the resulting estimates of the diffusion constant. The aver-
age diffusion constant is approximately D 	 1.4  106
cm2/s.
The magnitude of the diffusion constant was also esti-
mated by integrating over the velocity autocorrelation func-
tion depicted in Fig. 10. For the cases of trajectories T1, T3,
and T4, the initial decay up to 2.0 ps is well approximated
FIGURE 6 The atomic solvent exposed surface area contributed by the
central hydrophobic cluster LVFFA (top) and the total peptide (bottom)
over the length of the four simulation runs.
FIGURE 7 The averaged root-mean-square atomic coordinate deviation
from the average peptide structure computed over the each of the four
simulation runs.
FIGURE 8 The difference between the values of the experimentally
measured H proton chemical shift at temperature T and at temperature
T 	 5°C (H 	 H(T)  H(5°C)) as a function of the temperature over a
range of 5 to 35°C. Small values indicate regions of the peptide where the
average structure is stable over the measured temperature range (Zhang,
1999).
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by an exponential function of the form C(t) 	 
v2
exp(t/
) where the mean square velocity 
v2 	 0.235
Å2/ps2 	 2,350 m2/s2 for a root mean square velocity of 47
m/s as expected from kinetic theory for a peptide of mass
M 	 2902 g/mol. Using a simple fit to the exponential
model where 
 	 0.27 ps, the estimate for the diffusion
constant is D 	 2.1  106 cm2/s. This value is slightly
larger than, but in reasonable agreement with, D values
derived from fits to the mean-square displacement data. The
experimentally measured value of the diffusion constant for
the peptide in aqueous solution at this temperature is Dexp	
1.4  106 cm2/s (Tseng et al., 1999). (A previous estimate
of the diffusion constant was 1.6  107 cm2/s, Kusumoto
et al., 1998)
Suppose that we interpret the magnitude of the diffusion
constant using a Langevin model. What is the value of the
friction constant, 	, that results? Taking
D kBT/	 (11)
we find that 	 	 1.9  1011 kg/s. Now suppose that we
use the Stokes-Einstein relation
	  6rH (12)
where  	 0.01 poise is the viscosity of the water solvent.
We estimate that the hydrodynamic radius of the peptide is
rH 	 10 Å, which is in reasonable agreement with the
estimates of the peptide radius computed over our simulated
dynamics discussed in the following section.
In Fig. 11 we plot the dependence of the logarithm of the
diffusion constant for a number of molecules (glycine, su-
crose, ribonuclease, lysozyme, bovine serum albumin, and
hemoglobin) along with the computed value for the A
peptide as a function of the logarithm of the molecular mass.
Two fits are shown. The first fit is based on an approxima-
tion that the hydrodynamic radius aH scales as M1/3 where
M is the mass of the molecule. The result is
D 3.0 105
1
M1/3 cm
2/s . (13)
This fit should work well if the molecule is closely packed.
However, as we have seen, the peptide structure is some-
what extended in solution. A better fit to the mass scaling of
the diffusion constant is achieved with
D 5.1 105
1
M2/5 cm
2/s (14)
although the mass scaling is less well founded. If the peptide
was a linear chain we might expect rH to scale as the peptide
FIGURE 9 The mean square atomic displacement as a function of time
for each of the four trajectories T1, T2, T3, and T4. The slope of the mean
square displacement is equal to 6D where D is the self-diffusion constant.
From this data were derived four estimates of the diffusion constant of the
peptide.
FIGURE 10 The velocity autocorrelation function for the center of mass
motion of the peptide as a function of time for each of the four trajectories
T1, T2, T3, and T4. For trajectories T1, T3, and T4, the decay is well
approximated by an exponential function.
FIGURE 11 The log-log plot of the diffusion constant as a function of
the molecular mass for a series of macromolecules (from experiment) and
the -amyloid peptide congener (from this work).
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radius of gyration which is expected to scale as M3/5 in
agreement with Flory theory (where excluded volume is
considered). However, the peptide is a branched polymer
that is well structured in a way that the ensemble of linear
chains is not. The measured result is a mass scaling that lies
between the close-packed scaling and the expectations of
the linear chain model. Although the calculation of the
diffusion constant of the peptide does not provide a precise
measure of the structure of the peptide, it certainly gives an
indication that the peptide in solution is not in a completely
extended conformation but is rather structured in a more
compact way.
End-to-end distance fluctuations
The end-to-end distance in the peptide computed over the
four dynamical trajectories is depicted in Fig. 12. The
results clearly indicate that the global structure of the pep-
tide is largely intact throughout simulations T1, T2, and T4.
This is true in spite of the fact that by a number of measures,
including the magnitude of mean-square atomic fluctuations
and NMR order parameters, the terminal ends of the peptide
are largely disordered. In simulation T3 the behavior is quite
different, as there is a strong drift in the end-to-end distance
towards shorter distances.
To create a point of reference for our simulation results,
it is useful to compare them with a standard of a simple
solvable model of an ideal linear polymer. For that model,
the end-to-end distribution W(re) is a expected to be a
Gaussian function
Wre 
 32
re2
3/2
exp 32
re2 re2 (15)
where 
re2 is the square of the end-to-end distance averaged
over all configurations. For an ideal freely jointed chain,
where external forces and hydrodynamic effects are ig-
nored, we expect that 
re2 	 Nl2 where l2 is the mean-square
bond length along the chain and N is the number of bonds.
Taking the C  C distance to be 3.84 Å and N 	 25 the
predicted value is Re 	 
re21/2 	 19.2 Å. That value sits
slightly above the computed values shown in Fig. 12 indi-
cating that the effect of intramolecular interactions and
solvation is to reduce the end-to-end distance somewhat
relative to the predictions of the freely jointed chain.
Of course, the difference is greater than the deviation of
the mean value indicates. This is clearly demonstrated by
Fig. 13, which shows the distribution of re values computed
for the simulated peptide dynamics. In the distribution of re
the difference is even more pronounced. Unlike a freely
jointed chain, the peptide is structured and the range of
values of the re is severely restricted. The distribution is
well approximated by a Gaussian function
Wr exp
 r222  (16)
where  and  are the average and the standard deviation,
respectively, calculated from the set of data. The parameters
of the fits are listed in Table 1.
A point of comparison with experiment is found in the
quasielastic light scattering data of Teplow and coworkers
(Lomakin, 1997). They measured diffusion constants,
which were then interpreted using a Stokes-Einstein analy-
sis (see Eqs. 11 and 12) to derive a distribution of values of
the hydrodynamic radius rH for the peptide. The distribution
of radii attributed to the peptide monomer was shown to be
spread between 10 and 20 Å. That distribution is in good
agreement with the distribution of peptide end-to-end dis-
tances derived from our simulations (see Fig. 13).
Radius of gyration
The radius of gyration is a convenient measure of the spatial
extent of the peptide during the simulated dynamics. The
FIGURE 12 The end-to-end distance for the peptide computed for the
trajectories T1, T2, T3, and T4.
FIGURE 13 The distribution of the instantaneous values of the end-to-
end distance of the peptide computed for the trajectories T1, T2, T3, and
T4.
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time dependence of this quantity is depicted in Fig. 14 for
the four dynamical simulations. The resulting values pro-
vide an estimate of the spatial extent of the molecule that is
in good agreement with the estimate of the molecule’s
hydrodynamic radius.
The time average of the radius of gyration is approxi-
mately 9.2 Å, which is in close correspondence with the
estimate of the hydrodynamic radius rH 	 10 Å computed
from the diffusion constant using the Stokes-Einstein relation.
In the simplest approximation of an ideal polymer where
excluded volume is ignored, the radius of gyration distribu-
tion W(rg) is a expected to be strongly weighted Gaussian
Wrg rg6exp 72
rg2 rg2 . (17)
The radius of gyration was binned over the four simulations
and the distributions are plotted in Fig. 15. A fit to the data
using the computed values of 
rg2 is shown for comparison
and a Gaussian distribution function (using Eq. 16). This fit
approximates the actual distribution satisfactorily over most
of its range. The parameters of the fits are listed in Table 2.
We can estimate the radius of gyration from the freely
jointed chain model to be

rg2
1
6 N
N 2N 1l2 (18)
where N is the number of bonds in the chain and l is the root
mean square bond length. In the limit of larger N one finds
that 
rg2 	
1
6 
re
2. For this molecule, we find that on average

re21/2 	 16 Å, so that we would estimate 
rg21/2 	 6.5 Å,
which is somewhat less than our computed value in the
range of 
rg21/2	 10 Å. This difference results from the fact
that the end-to-end distance does not fluctuate widely as is
expected in the freely jointed chain model. The peptide has
a definite core structure that restricts the range of probable
end-to-end distances in the peptide. In this case, that leads to
values of 
re21/2 that are smaller than expected.
Characterizing internal motions: Lipari-Szabo
NMR order parameters
In Table 3 are listed the computed S2 order parameters for
the four nanosecond simulations of the peptide. The exper-
imentally measured values are listed for comparison. The
same data are plotted in Fig. 16 to show better the overall
trends across the peptide’s primary structure. Comparing
the table of S2 values with the computed RMS fluctuations
(see Fig. 7), the correlation is quite good: large values of S2
correspond with small values of the RMS fluctuation from
the average peptide structure.
TABLE 1 The parameters (in Å) of the Gaussian fits to the
distribution of end-to-end distances computed over the
four trajectories
End to end
Trajectory  
1 16.0 0.92
2 16.2 0.96
3 (1st Gaussian) 10.6 1.93
3 (2nd Gaussian) 16.2 0.94
4 15.8 0.87
FIGURE 14 The radius of gyration of the peptide computed for the
trajectories T1, T2, T3, and T4.
FIGURE 15 The distribution of the instantaneous values of the radius of
gyration of the peptide computed for the trajectories T1, T2, T3, and T4.
TABLE 2 The parameters (in Å) of the Gaussian fits to the
distribution of radii of gyration computed over the
four trajectories
Radius of gyration
Trajectory  
1 8.93 0.24
2 9.45 0.26
3 9.39 0.29
4 (1st Gaussian) 8.67 0.15
4 (2nd Gaussian) 9.40 0.19
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Simulations T1 and T2 show significant correlations that
extend to include the LVFFA and VGS regions. In the T1
simulation, the N terminal end of the peptide shows the
higher degree of correlation. In the T2 simulation, it is the
C terminal end of the peptide that shows the higher level of
correlation.
In the T3 run there is significantly less correlation than in
the other three trajectories. There are two regions (from
Gln15 to Phe19 and Glu22 to Asp23) with larger values of
S2. Note that the FA end of the LVFFA region shows lower
values indicating that the LVFFA cluster is disrupted. The
structure of the VGSN turn region also appears to be dis-
rupted. It would be interesting to know if that is a conse-
quence of, or reason for, the relatively unstructured nature
of the peptide dynamics over that trajectory. In the T3 run,
the peptide structure is more open or loose. For example, the
Phe19 and Phe20 residues interact with Gly25 and Asp23.
Those interactions are not seen in any other trajectory.
In the T3 simulation, Ala21 forms hydrogen bonds not at
all or at a very low frequency. This is quite different from
all other trajectories in which it is always part of a hydrogen
bonding pair. In addition, Leu17 and Val18 do not form any
hydrogen bonds with atoms in the region LVFFAEDVG-
SNK. This could explain the disruption of the core and the
fact that S2 	 0.1 for Ala21 in the T3 simulation.
The simulation T4 shows a much higher degree of struc-
ture than the other simulations. Values for S2 exceed 0.5
from Glu11 to Leu34. There are particularly large values in
the LVFFA region. This is the simulation that presents the
highest number of H-bonds over the entire run. Moreover,
the structure of the peptide is significantly more compact in
the T4 run than in the other simulations.
Note that the Glu22 shows large S2 values throughout all
four runs. It is the Glu22 residue that is mutated in the E22Q
Dutch mutant. This observation is in line with the notion
that the WT is less flexible than the E22Q Dutch mutant in
the peptide monomer. The greater flexibility in the mutant
form may contribute to the faster addition of the peptide
monomer to the existing fibril and a larger rate of fibril
elongation.
SUMMARY AND CONCLUSIONS
The simulation of four nanosecond trajectories of the wild-
type congener amyloid (10–35)-NH2 peptide solvated by
2113 water molecules in a rhombic dodecahedral cell was
performed. The analysis of the simulations focused on com-
puting quantities to characterize the structure and dynamics
of the peptide. This computational study employed a theo-
retical model of the peptide in aqueous solution and has
provided a number of tests of the model against the results
of experiments probing the peptide structure, rate of self-
diffusion, conformational fluctuations, and key stabilizing
interactions. Particular attention was paid to observables
that can be or have been measured experimentally so as to
test and validate the theoretical model. The results led to the
following conclusions.
1. The computed values of the peptide diffusion constant
are consistently on the order of D 	 1.4  106cm2/s in
good agreement with the experimentally measured value of
Dexp 	 1.4  106cm2/s (Tseng et al., 1999). If the simu-
TABLE 3 The computed and experimentally derived values
of the S2 order parameter
Residue
S2
T1 T2 T3 T4 Experimental
Tyr10 0.13 0.16 0.08 0.48
Glu11 0.44 0.18 0.36 0.51
Val12 0.67 0.32 0.54 0.69
His13 0.72 0.24 0.23 0.84
His14 0.29 0.27 0.42 0.82
Gln15 0.72 0.54 0.57 0.79
Lys16 0.81 0.59 0.73 0.85
Leu17 0.64 0.41 0.79 0.80
Val18 0.33 0.63 0.80 0.84 0.68 0.05
Phe19 0.58 0.75 0.69 0.85 0.75 0.05
Phe20 0.71 0.69 0.48 0.86 0.79 0.05
Ala21 0.60 0.57 0.10 0.77
Glu22 0.65 0.65 0.59 0.75
Asp23 0.54 0.18 0.55 0.78
Val24 0.68 0.45 0.34 0.74 0.75 0.05
Gly25 0.74 0.61 0.58 0.70 0.76 0.05
Ser26 0.55 0.55 0.33 0.75
Asn27 0.32 0.55 0.37 0.82
Lys28 0.69 0.52 0.43 0.82
Gly29 0.58 0.58 0.34 0.71 0.64 0.06
Ala30 0.38 0.38 0.34 0.68
Ile31 0.09 0.63 0.28 0.60
Ile32 0.29 0.75 0.23 0.74
Gly33 0.26 0.54 0.32 0.60 0.54 0.06
Leu34 0.33 0.22 0.39 0.51
Met35 0.40 0.25 0.56 0.43
The residues for which the values of the S2 order parameter were experi-
mentally measured are shown in bold. Data for key residue Glu22 are
underlined.
FIGURE 16 Plot of the structural parameter S2 for the four simulations.
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lated peptide structure was significantly different from that
of the actual peptide in aqueous solution, the diffusion
constants could have been quite different in magnitude. The
magnitude of D is consistent with a relatively compact
peptide structure.
2. The computed values of the radius of gyration for the
peptide, in three of the four simulations, are consistently in
the range of 
rg21/2 	 10 Å. The computed value of the
hydrodynamic radius, rH 	 9.2 Å is quite similar to this
value, indicating that the assumptions underlying the use of
the Stokes-Einstein relation are reasonably well satisfied by
the dynamics of the A-peptide congener in aqueous solution.
3. Computed NMR order parameters (S2) are in good
agreement with experimentally measured values for three of
the four simulations. Evidence suggests that the LVFFA
cluster and VGSN turn are cooperatively stabilized through
intramotif hydrogen bonds.
4. Simulations suggest that the LVFFA hydrophobic clus-
ter and VGSN turn are particularly stable in agreement with
chemical shift data. The general trends in the magnitude of
the root-mean-square atomic fluctuations compare well with
the trends in the magnitude of the chemical shift data.
All of these results suggest that the theoretical model
employed provides an accurate representation of the peptide
structure and dynamics in solution.
An understanding of the mechanism of in vivo amyloid
fibril formation and elongation is an important goal that is
best reached by a combination of experimental and compu-
tational studies. Our simulation study indicates that the
peptide is somewhat disordered in solution. As a result,
characterization of the peptide structure and dynamics is
difficult using NMR probes alone. The solution structure of
the monomeric peptide is central to the understanding of
peptide-peptide association and aggregation to form amy-
loid fibrils. To unravel the mechanism of amyloid fibril
formation, it will be necessary to understand the solution
structure and dynamics of the monomeric peptide in solution.
Future directions in the simulation of the A peptide
should consist of the simulation of mutant forms of the
peptide that show strongly differing rates of fibril elonga-
tion. The details of peptide-peptide interactions must be
explored to recognize the importance of monomeric peptide
conformational transitions in peptide aggregation and pro-
tofibril formation.
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